Pharmacies, AGs Claim Sides On FDA's Generic Label Plan

Law360, Los Angeles (March 12, 2014, 6:16 PM EDT) -- Dozens of state attorneys general and more than 20 pharmacies and trade groups squared off on opposing sides Wednesday over the U.S. Food and Drug Administration’s controversial plan to let generic-drug makers independently change their warning labels.

In separate letters to the FDA, the attorneys general praised the proposed rule as an incentive for generics manufacturers to keep a close eye on their drugs, while the pharmacies argued the potential for differing warnings would confuse the market and eventually drive up prices.

The current rules prevent...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.